Skip to main content

Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).

Publication ,  Journal Article
Thomas, LE; Bonow, RO; Pencina, MJ
Published in: JAMA Cardiol
September 1, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

September 1, 2020

Volume

5

Issue

9

Start / End Page

988 / 990

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pneumonia, Viral
  • Pandemics
  • Humans
  • Coronavirus Infections
  • Coronavirus
  • COVID-19
  • Betacoronavirus
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin Receptor Antagonists
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thomas, L. E., Bonow, R. O., & Pencina, M. J. (2020). Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, 5(9), 988–990. https://doi.org/10.1001/jamacardio.2020.1874
Thomas, Laine E., Robert O. Bonow, and Michael J. Pencina. “Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).JAMA Cardiol 5, no. 9 (September 1, 2020): 988–90. https://doi.org/10.1001/jamacardio.2020.1874.
Thomas LE, Bonow RO, Pencina MJ. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):988–90.
Thomas, Laine E., et al. “Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).JAMA Cardiol, vol. 5, no. 9, Sept. 2020, pp. 988–90. Pubmed, doi:10.1001/jamacardio.2020.1874.
Thomas LE, Bonow RO, Pencina MJ. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Sep 1;5(9):988–990.

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

September 1, 2020

Volume

5

Issue

9

Start / End Page

988 / 990

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pneumonia, Viral
  • Pandemics
  • Humans
  • Coronavirus Infections
  • Coronavirus
  • COVID-19
  • Betacoronavirus
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin Receptor Antagonists